Elisabeth Mlczoch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elisabeth Mlczoch has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Barbara Ulm
2 shared publicationsDaniela Prayer
Division of Neuroradiology and Musculoskeletal Radiology, Department of Radiology Medical University Vienna Austria
2 shared publicationsManfred Marx
Division of Paediatric Cardiology; Department of Paediatrics and Adolescent Medicine; Medical University of Vienna; Vienna Austria
2 shared publicationsSophie Frantal
Department for Medical Statistics Medical University of Vienna Austria
2 shared publicationsUlrike Salzer-Muhar
2 shared publicationsA. Hanslik
Pediatric Heart Center, Department of Pediatrics and Adolescent Medicine, Division for Pediatric Cardiology Medical University of Vienna Vienna Austria
1 shared publication
Latest Publications
- Open Access
- 10 June 2014
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 45 (5) , 618-621
Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus
Tuberous sclerosis complex (TSC) is a genetic disorder characterized by abnormal cell proliferation and tumor growth in a number of organ systems, primarily the brain, kidneys, eyes and heart. Clinical symptoms vary according to the location of the tumor. The most common disorders are seizures, neurodevelopmental disorders, renal failure and arrhythmias. TSC was found to be influenced by inhibitors of the protein kinase mammalian target of rapamycin (mTOR), which regulates abnormal cellular proliferation. mTOR inhibitors have been studied effectively in patients with subependymal giant‐cell astrocytomas and renal angiolipomas in the context of TSC. We describe a prenatally diagnosed case of giant rhabdomyoma, due to right ventricular outflow tract obstruction, which presented as a duct‐dependent lesion. Postnatal treatment with the mTOR inhibitor everolimus initiated significant regression of the cardiac tumor. This finding suggests that mTOR inhibitor therapy is an option for giant rhabdomyomas that develop in the neonatal period. Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.
- 10 June 2014
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 45 (5) , 618-621
Open AccessPrenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus
Tuberous sclerosis complex (TSC) is a genetic disorder characterized by abnormal cell proliferation and tumor growth in a number of organ systems, primarily the brain, kidneys, eyes and heart. Clinical symptoms vary according to the location of the tumor. The most common disorders are seizures, neurodevelopmental disorders, renal failure and arrhythmias. TSC was found to be influenced by inhibitors of the protein kinase mammalian target of rapamycin (mTOR), which regulates abnormal cellular proliferation. mTOR inhibitors have been studied effectively in patients with subependymal giant‐cell astrocytomas and renal angiolipomas in the context of TSC. We describe a prenatally diagnosed case of giant rhabdomyoma, due to right ventricular outflow tract obstruction, which presented as a duct‐dependent lesion. Postnatal treatment with the mTOR inhibitor everolimus initiated significant regression of the cardiac tumor. This finding suggests that mTOR inhibitor therapy is an option for giant rhabdomyomas that develop in the neonatal period. Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.
- 1 April 2014
- Published by Wiley in Acta Paediatrica
- Vol. 103 (5) , e188-e193
Radiofrequency catheter ablation can be performed with high success rates and very low complication rates in children and adolescents
Radiofrequency catheter ablation is a standard treatment for tachyarrhythmia in children. Recently, several centres using cryoenergy for ablation have reported high success and low complication rates, but an increased risk of recurrence of arrhythmia. The aim of this study was to report success, complications and recurrence rates for radiofrequency catheter ablation in children under current conditions.
- 1 April 2014
- Published by Wiley in Acta Paediatrica
- Vol. 103 (5) , e188-e193
Radiofrequency catheter ablation can be performed with high success rates and very low complication rates in children and adolescents
Radiofrequency catheter ablation is a standard treatment for tachyarrhythmia in children. Recently, several centres using cryoenergy for ablation have reported high success and low complication rates, but an increased risk of recurrence of arrhythmia. The aim of this study was to report success, complications and recurrence rates for radiofrequency catheter ablation in children under current conditions.
- 23 December 2013
- Published by Wiley in Prenatal Diagnosis
- Vol. 34 (3) , 273-278
Fetal cardiac disease and fetal lung volume: an in utero MRI investigation
Objectives: Magnetic resonance imaging (MRI) is a powerful, noninvasive tool to study fetal lung volumes after 18 weeks of gestation in vivo. In neonates with congenital heart disease (CHD), proper lung function is essential for postnatal survival. Antenatal detection of abnormal pulmonary development may help to optimize prenatal and perinatal management of at‐risk fetuses. We aimed to investigate lung volumes in fetuses with prenatally diagnosed heart disease.Methods: A cross‐sectional, retrospective study of 105 consecutive singleton pregnancies with CHD and a control, non‐CHD group (n = 115), that underwent fetal MRI was performed. The heart defects detected were divided into four groups. Lung volumes of fetuses with heart disease were compared with control, non‐CHD fetuses. In addition, z‐scores of lung volumes were calculated for the CHD group (normal range z‐scores from −2–+2).Results: As a group, fetuses with CHD have significantly smaller lung volumes compared with control fetuses when corrected by gestational age (GA) (p = 0.049). Of the 105 CHD fetuses studied, 18 had lung volumes with a z‐score < −2. Fetuses with different types of CHD showed similar lung volumes.Conclusion: Our data indicate that postpartum pulmonary symptoms and outcome in neonates with congenital heart disease may be attributed to the cardiac disease itself and in part to smaller lung volumes. © 2013 John Wiley & Sons, Ltd.
- 23 December 2013
- Published by Wiley in Prenatal Diagnosis
- Vol. 34 (3) , 273-278
Fetal cardiac disease and fetal lung volume: an in utero MRI investigation
Objectives: Magnetic resonance imaging (MRI) is a powerful, noninvasive tool to study fetal lung volumes after 18 weeks of gestation in vivo. In neonates with congenital heart disease (CHD), proper lung function is essential for postnatal survival. Antenatal detection of abnormal pulmonary development may help to optimize prenatal and perinatal management of at‐risk fetuses. We aimed to investigate lung volumes in fetuses with prenatally diagnosed heart disease.Methods: A cross‐sectional, retrospective study of 105 consecutive singleton pregnancies with CHD and a control, non‐CHD group (n = 115), that underwent fetal MRI was performed. The heart defects detected were divided into four groups. Lung volumes of fetuses with heart disease were compared with control, non‐CHD fetuses. In addition, z‐scores of lung volumes were calculated for the CHD group (normal range z‐scores from −2–+2).Results: As a group, fetuses with CHD have significantly smaller lung volumes compared with control fetuses when corrected by gestational age (GA) (p = 0.049). Of the 105 CHD fetuses studied, 18 had lung volumes with a z‐score < −2. Fetuses with different types of CHD showed similar lung volumes.Conclusion: Our data indicate that postpartum pulmonary symptoms and outcome in neonates with congenital heart disease may be attributed to the cardiac disease itself and in part to smaller lung volumes. © 2013 John Wiley & Sons, Ltd.
- 1 March 2013
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 17 (2) , 153-160
Structural congenital brain disease in congenital heart disease: Results from a fetal MRI program
- 1 March 2013
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 17 (2) , 153-160
Structural congenital brain disease in congenital heart disease: Results from a fetal MRI program
- 25 February 2011
- Published by Springer Nature in Pediatric Cardiology
- Vol. 32 (5) , 678-680
Tachycardia-Induced Cardiomyopathy After Functional Closure of the Foramen Ovale in a Fetus
- 25 February 2011
- Published by Springer Nature in Pediatric Cardiology
- Vol. 32 (5) , 678-680
Tachycardia-Induced Cardiomyopathy After Functional Closure of the Foramen Ovale in a Fetus